Preferred Label : uridine monophosphate;

MeSH definition : 5'-Uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position.;

MeSH synonym : uridine 5'-monophosphate; uridylic acid; uridylic acids; monophosphate, uridine; 5'-monophosphate, uridine; uridine 5' monophosphate; acid, uridylic; acids, uridylic; UMP;

CISMeF synonym : uridine 5'-(dihydrogen phosphate);

MeSH CAS label : 5'-Uridylic acid;

MeSH Related Number : 58-97-9 (Uridine monophosphate);

Registry Number MeSH : 58-97-9;

Wikipedia link : https://en.wikipedia.org/wiki/Uridine monophosphate;

Codes EINECS : 200-408-0;

Is substance : O;

UNII : E2OU15WN0N;

InChIKey : DJJCXFVJDGTHFX-XVFCMESISA-N;

Details


Main resources

You can consult :

5'-Uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position.

http://publications.msss.gouv.qc.ca/msss/document-002023/
http://publications.msss.gouv.qc.ca/msss/document-002024/
http://publications.msss.gouv.qc.ca/msss/document-002025/
2022
false
false
false
Canada
French
practice guideline
patient care management
hepatitis C
quebec
hepatitis C
hepatitis C
antiviral agents
continuity of patient care
antiviral agents
drug interactions
acute disease
drug monitoring
hepatitis C, chronic
hepatitis C antibodies
hepatitis C
serologic tests
fibrosis, liver
predictive value of tests
elbasvir-grazoprevir drug combination
glecaprevir
pibrentasvir
ledipasvir, sofosbuvir drug combination
drug combinations
sofosbuvir-velpatasvir drug combination
voxilaprevir
liver cirrhosis
glecaprevir
quinoxalines
sulfonamides
benzofurans
drug combinations
imidazoles
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
Sofosbuvir
carbamates
Heterocyclic Compounds, 4 or More Rings
macrocyclic compounds

---
https://www.has-sante.fr/jcms/p_3224404/fr/harvoni
2020
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
administration, oral
ledipasvir, sofosbuvir drug combination
Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form)
antiviral agents
hepatitis C, chronic
child
adolescent
adult
sofosbuvir and ledipasvir
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate

---
https://www.has-sante.fr/jcms/p_3152635/fr/harvoni
2020
false
false
false
France
Sofosbuvir
treatment outcome
ledipasvir
ledipasvir, sofosbuvir drug combination
adult
adolescent
antiviral agents
drug combinations
hepatitis C, chronic
evaluation of the transparency committee
Harvoni
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate

---
https://www.has-sante.fr/portail/jcms/c_2848077/fr/harvoni-sofosbuvir/ledipasvir-antiviral-a-action-directe
https://www.has-sante.fr/portail/jcms/c_2848077/fr/harvoni
2018
false
false
false
France
French
evaluation of the transparency committee
administration, oral
treatment outcome
drug combinations
benzimidazoles
benzimidazoles
fluorenes
fluorenes
antiviral agents
antiviral agents
hepatitis C, chronic
guidelines for drug use
insurance, health, reimbursement
ledipasvir
ledipasvir
Sofosbuvir
Sofosbuvir
ledipasvir, sofosbuvir drug combination
ledipasvir, sofosbuvir drug combination
sofosbuvir and ledipasvir
adolescent
uridine monophosphate
uridine monophosphate
uridine monophosphate

---
http://circulaire.legifrance.gouv.fr/index.php?action=afficherCirculaire&hit=1&r=42484
http://circulaire.legifrance.gouv.fr/pdf/2017/08/cir_42484.pdf
2017
false
false
false
France
French
legislation
insurance, health, reimbursement
hepatitis C, chronic
elbasvir-grazoprevir drug combination
dasabuvir
legislation, drug
antiviral agents
ritonavir
Product containing ombitasvir and paritaprevir and ritonavir in oral dose form (medicinal product form)
ombitasvir
paritaprevir
direct acting antivirals
daclatasvir
administration, oral
Simeprevir
sofosbuvir-velpatasvir drug combination
ledipasvir, sofosbuvir drug combination
Multidisciplinary care conference (procedure)
Interdisciplinary medical team conference (procedure)
dasabuvir
ombitasvir
paritaprevir
daclatasvir
benzofurans
drug combinations
imidazoles
quinoxalines
Sofosbuvir
carbamates
Heterocyclic Compounds, 4 or More Rings
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
sulfonamides
uracil
uracil
anilides
macrocyclic compounds

---
http://www.has-sante.fr/portail/jcms/c_2728866/fr/reevaluation-des-antiviraux-d-action-directe-dans-le-traitement-de-l-hepatite-c
2016
false
false
false
France
French
guidelines for drug use
practice guideline
antiviral agents
hepatitis C, chronic
drug evaluation
Sofosbuvir
administration, oral
Simeprevir
direct acting antivirals
daclatasvir
ledipasvir
ledipasvir, sofosbuvir drug combination
drug therapy, combination
ritonavir
ombitasvir
paritaprevir
dasabuvir
drug resistance, viral
drug interactions
treatment outcome
daclatasvir
ombitasvir
paritaprevir
dasabuvir
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
imidazoles
anilides
carbamates
macrocyclic compounds
sulfonamides
uracil
uracil

---
http://www.has-sante.fr/portail/jcms/c_2633680/fr/antiviraux-d-action-directe
2016
false
false
false
France
French
evaluation of the transparency committee
adult
hepatitis C, chronic
drug therapy, combination
Sofosbuvir
antiviral agents
direct acting antivirals
daclatasvir
Simeprevir
ledipasvir, sofosbuvir drug combination
dasabuvir
drug combinations
ombitasvir
ritonavir
paritaprevir
fibrosis, liver
risk
has patient
hepacivirus
Infections
autoimmune diseases
hepatic fibrosis, nos
fibrosis
hepatitis C virus
human enterovirus 72
hepatitis C, chronic
business
liver cirrhosis
socialism
patients
chronic infectious disease
guideline
antiviral agents
chronic hepatitis, nos
health
case management
hepatitis c virus
hepatitis a virus
dasabuvir
ombitasvir
paritaprevir
daclatasvir
fibrosis
commerce
patients
guideline
benzimidazoles
fluorenes
uridine monophosphate
sulfonamides
uracil
uracil
anilides
carbamates
macrocyclic compounds
imidazoles

---
https://afef.asso.fr/wp-content/uploads/2018/06/VF-INTERACTIF-RECO-VHC-AFEF-v2103.pdf
http://www.infectiologie.com/UserFiles/File/medias/Recos/2015-juin-Recommandations-AFEF-Hepatite-C.pdf
2016
false
false
true
false
France
French
hepatitis C, chronic
practice guideline
severity of illness index
hepatitis C, chronic
antiviral agents
comorbidity
genotype
daclatasvir
ledipasvir
ribavirin
treatment outcome
drug resistance, viral
pregnancy
patient education as topic
liver cirrhosis
liver transplantation
recurrence
renal insufficiency
child
adolescent
drug users
hiv infections
acute disease
Acute hepatitis C
Simeprevir
Sofosbuvir
ledipasvir
ledipasvir, sofosbuvir drug combination
daclatasvir
imidazoles
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate

---
Direct-acting antivirals, used for hepatitis C, may reactivate hepatitis B
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2016/61274a-fra.php
2016
false
false
false
Canada
French
English
pharmacovigilance note
hepatitis C, chronic
adult
direct acting antivirals
antiviral agents
Hepatitis B reactivation
hepatitis B
risk assessment
product surveillance, postmarketing
canada
patient education handout
risk
daclatasvir
Sofosbuvir
Simeprevir
velpatasvir
ledipasvir
ledipasvir, sofosbuvir drug combination
dasabuvir
ritonavir
sofosbuvir-velpatasvir drug combination
daclatasvir
dasabuvir
carbamates
Heterocyclic Compounds, 4 or More Rings
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
imidazoles
sulfonamides
uracil
uracil
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2022100/fr/harvoni
http://www.has-sante.fr/portail/jcms/c_2022100/fr/harvoni-sofosbuvir/ledipasvir-association-fixe-dantiviraux-a-action-directe
2015
false
false
false
France
French
evaluation of the transparency committee
administration, oral
treatment outcome
drug combinations
benzimidazoles
benzimidazoles
fluorenes
fluorenes
antiviral agents
antiviral agents
hepatitis C, chronic
adult
guidelines for drug use
Hepatitis C virus genotype 1 (organism)
Hepatitis C virus genotype 3 (organism)
Hepatitis C virus genotype 4 (organism)
insurance, health, reimbursement
ledipasvir
ledipasvir
Sofosbuvir
Sofosbuvir
ledipasvir, sofosbuvir drug combination
ledipasvir, sofosbuvir drug combination
sofosbuvir and ledipasvir
uridine monophosphate
uridine monophosphate
uridine monophosphate

---
https://www.ema.europa.eu/medicines/human/EPAR/Harvoni
2014
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
drug combinations
benzimidazoles
benzimidazoles
fluorenes
fluorenes
antiviral agents
antiviral agents
adult
hepatitis C, chronic
administration, oral
tablets
NS-5 protein, hepatitis C virus
NS-5a protein, hepatitis C virus
NS-5b protein, hepatitis C virus
treatment outcome
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
ledipasvir
ledipasvir
Sofosbuvir
Sofosbuvir
ledipasvir, sofosbuvir drug combination
ledipasvir, sofosbuvir drug combination
sofosbuvir and ledipasvir
viral nonstructural proteins
uridine monophosphate
uridine monophosphate
uridine monophosphate

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=61206641
2014
false
false
false
France
French
summary of product characteristics
package leaflet
dandruff
seborrhea sicca
pill, nos
compression, nos
tablets
dandruff
uridine monophosphate

---
Nous contacter.
17/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.